Phase Ii Study Of Xl184 (Bms 907351), An Inhibitor Of Met, Vegfr2, And Ret, In Patients (Pts) With Progressive Glioblastoma (Gb)Patrick Y Wen,Michael D Prados,David Schiff,David A Reardon,Timothy F Cloughesy, T Mikkelsen,Tracy T Batchelor,Jan Drappatz,Marc C Chamberlain,J F De GrootJOURNAL OF CLINICAL ONCOLOGY(2010)引用 53|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要